PL3650024T3 - Kompozycja farmaceutyczna do podawania donosowego, zawierająca ryfampicyny, do leczenia otępienia - Google Patents

Kompozycja farmaceutyczna do podawania donosowego, zawierająca ryfampicyny, do leczenia otępienia

Info

Publication number
PL3650024T3
PL3650024T3 PL18828851.8T PL18828851T PL3650024T3 PL 3650024 T3 PL3650024 T3 PL 3650024T3 PL 18828851 T PL18828851 T PL 18828851T PL 3650024 T3 PL3650024 T3 PL 3650024T3
Authority
PL
Poland
Prior art keywords
rifampicins
pharmaceutical composition
nasal administration
treating dementia
dementia
Prior art date
Application number
PL18828851.8T
Other languages
English (en)
Inventor
Takami Tomiyama
Tomohiro Umeda
Original Assignee
Medilabo Rfp, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medilabo Rfp, Inc. filed Critical Medilabo Rfp, Inc.
Publication of PL3650024T3 publication Critical patent/PL3650024T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL18828851.8T 2017-07-06 2018-07-05 Kompozycja farmaceutyczna do podawania donosowego, zawierająca ryfampicyny, do leczenia otępienia PL3650024T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017132955 2017-07-06
PCT/JP2018/025512 WO2019009359A1 (ja) 2017-07-06 2018-07-05 経鼻投与用医薬組成物

Publications (1)

Publication Number Publication Date
PL3650024T3 true PL3650024T3 (pl) 2024-03-18

Family

ID=64951007

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18828851.8T PL3650024T3 (pl) 2017-07-06 2018-07-05 Kompozycja farmaceutyczna do podawania donosowego, zawierająca ryfampicyny, do leczenia otępienia

Country Status (13)

Country Link
US (1) US11583494B2 (pl)
EP (1) EP3650024B1 (pl)
JP (1) JP7146281B2 (pl)
CN (1) CN110831598A (pl)
CA (1) CA3068690A1 (pl)
DK (1) DK3650024T3 (pl)
ES (1) ES2970909T3 (pl)
FI (1) FI3650024T3 (pl)
HU (1) HUE065421T2 (pl)
MX (1) MX2020000144A (pl)
PL (1) PL3650024T3 (pl)
PT (1) PT3650024T (pl)
WO (1) WO2019009359A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102051624B1 (ko) * 2018-11-30 2019-12-02 아밀로이드솔루션 주식회사 트리플루프로마진 또는 이의 약학적으로 허용가능한 염을 유효성분으로 포함하는 퇴행성 뇌질환 치료용 약학 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0675126A1 (en) 1993-10-20 1995-10-04 Teijin Limited Amyloid beta-protein agglutination and/or deposition inhibitor

Also Published As

Publication number Publication date
PT3650024T (pt) 2023-12-14
DK3650024T3 (da) 2023-12-04
EP3650024B1 (en) 2023-10-25
EP3650024A1 (en) 2020-05-13
JP7146281B2 (ja) 2022-10-04
JPWO2019009359A1 (ja) 2020-07-27
HUE065421T2 (hu) 2024-05-28
US20200129426A1 (en) 2020-04-30
MX2020000144A (es) 2020-07-22
WO2019009359A1 (ja) 2019-01-10
CN110831598A (zh) 2020-02-21
ES2970909T3 (es) 2024-05-31
EP3650024A4 (en) 2021-04-07
US11583494B2 (en) 2023-02-21
CA3068690A1 (en) 2019-01-10
FI3650024T3 (fi) 2023-12-12

Similar Documents

Publication Publication Date Title
IL290823A (en) Pharmaceutical preparations for combination therapy
PT3616720T (pt) Composição medicinal para tratamento de cancro
IL268316B (en) Pharmaceutical preparations for combined treatment
ZA201906613B (en) Pharmaceutical compositions for combination therapy
ZA201905510B (en) Pharmaceutical compositions for combination therapy
EP3344325A4 (en) LOCAL ADMINISTRATION OF MEDICAMENTS FOR THE TREATMENT OF ASTHMA
IL261278A (en) Pharmaceutical compositions for the treatment of cancer
ZA201803320B (en) Pharmaceutical compositions for treating pain
IL275525A (en) A pharmaceutical preparation for the treatment of cancer
EP3375443A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF RESPIRATORY DISEASES
HK1245646A1 (zh) 口服給藥用醫藥組合物
IL268708B (en) Pharmaceutical preparations for combined treatment
HK1259373A1 (zh) 用於治療糖尿病的藥物製劑
HK1246146A1 (zh) 用於治療真菌病的藥物組合物
HUE065421T2 (hu) Nazális adagolású rifampicint tartalmazó gyógyszerészeti készítmény demencia kezelésére
EP3338771A4 (en) PHARMACEUTICAL COMPOSITION COMPRISING A COMBINATION OF TRAMADOL-ETORICOXIB CHLORHYDRATE FOR THE TREATMENT OF PAIN
GB201621559D0 (en) A method for the preparation of a delivery drug delivery system and a composition therefor
EP3461490C0 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HEMORRHOIDAL DISEASES
HK1255631A1 (zh) 用於預防和治療睡眠障礙的藥物組合物
GB201714241D0 (en) Pharmaceutical compositions for the treatment of proteinopathies
EP3348279A4 (en) MEDICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF INFLAMMATORY RESPIRATORY DISEASES
EP3253379A4 (en) Pharmaceutical composition for the treatment of obesity